Report overview
The Transcatheter Heart Valve Replacement and Repair industry can be broken down into several segments, TAVR, TPVR and TMVR.
Valvular heart diseases are associated with the person?s advancing age, caused by the congenital defects or inefficiency of valves to function. Valve dysfunction results in restricting physical activities that leads to decline in quality of life and even death. Hence, due to these reasons many years have been spent on developing heart valve devices in order to repair and replace the damaged heart valves. Over the past few years innovation and recent technological advancements have resulted in manufacturing of transcatheter heart valve that are less risky and need minimally invasive surgical procedure. Increase in number of people with valvular heart disease and rise in demand for minimally invasive surgical procedure will augment the growth of transcatheter heart valve replacement industry in the near future.
This report aims to provide a comprehensive presentation of the global market for Transcatheter Heart Valve Replacement and Repair, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Heart Valve Replacement and Repair. This report contains market size and forecasts of Transcatheter Heart Valve Replacement and Repair in global, including the following market information:
Global Transcatheter Heart Valve Replacement and Repair Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Transcatheter Heart Valve Replacement and Repair market was valued at US$ 6136.5 million in 2022 and is projected to reach US$ 15880 million by 2029, at a CAGR of 14.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Transcatheter Heart Valve Replacement and Repair includes TAVR, TPVR and TMVR. The proportion of TAVR in 2019 is about 80%.
North America and Europe are the largest consumption place, with a revenue market share nearly 95% in 2019. APAC has the highest growth in the market. The market is expected to grow at a faster pace due to significant developments and sales in countries such as India, Malaysia, South Korea and China.
Market competition is not intense. Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
We surveyed the Transcatheter Heart Valve Replacement and Repair companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transcatheter Heart Valve Replacement and Repair Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, by Type, 2022 (%)
TAVR
TPVR
TMVR
Global Transcatheter Heart Valve Replacement and Repair Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Global Transcatheter Heart Valve Replacement and Repair Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transcatheter Heart Valve Replacement and Repair revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transcatheter Heart Valve Replacement and Repair revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transcatheter Heart Valve Replacement and Repair, market overview.
Chapter 2: Global Transcatheter Heart Valve Replacement and Repair market size in revenue.
Chapter 3: Detailed analysis of Transcatheter Heart Valve Replacement and Repair company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transcatheter Heart Valve Replacement and Repair in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
